IRS Logo
Print - Click this link to Print this page

Qualifying Therapeutic Discovery Project Grants for the State of Wisconsin

The listings below represent the applicants that have been awarded a Qualifying Therapeutic Discovery Program Grant.

The project descriptions below were extracted from the applicant certification forms as submitted.

Wisconsin $ 12,886,764.62
Applicant Name Project Name Grants Awarded for 2009 Grants Awarded for 2010
Addiction Therapeutix, Inc. Addition Therapeutix - Opioid Addiction $ 2,308.75 $ 41,551.75
Addiction Therapeutix, Inc. Addiction Therapeutix-Alcoholism & Co-Morbid Anxiety $ 40,922.00 $ 69,079.00
AhR Pharmaceuticals Inc Development of ITE into an Efficacious and Sustainable but Low Side-Effect Therapeutic Agent in Combating Cancer $ 883.44 $ 3,550.00
BioSentinel, Inc. Botulinum neurotoxin detection and antidotes/antagonists:  A model of cost-effective drug development for unmet biothreat and patient safety needs $ 244,479.24  
Botanic Oil innovations, Inc. Phase 1 IND Clinical Trial of Novel Biotherapeutic for cancer treatment   $ 137,285.75
Cambridge Major Laboratories Inc Advanced Development of Anti-Cancer Drug - Abiraterone ACetate $ 244,479.25  
cdi Bioscience, Inc High Yield Protein Technology and Cell Lines for Biologic Therapeutics $ 197,160.50 $ 47,318.74
Cellectar, Inc. I-131-CLR1404 For Cancer Therapy $ 244,479.24  
Cellular Dynamics International Inc (DCI) Efficient, large -scale and parrallel manufacture of induced pluripotent stem cell (iPSC) panels. $ 244,479.25  
Cellular Dynamics International, Inc ("CDI") Neurons derived from human induced pluripotent stem cells (iPSCs) $ 222,120.00 $ 22,359.25
Cellular Dynamics International, Inc. ("CDI") Endothelial cells derived from human induced pluripotent stem cells (iPSCs) $ 27,764.50 $ 216,714.75
Cellular Dynamics International, Inc.("CDI") Hepatocytes derived from human induced pluripotent stem cells (iPSCs) $ 101,805.50 $ 142,673.75
Compact Particle Acceleration Corporation (CPAC) Highly Compact and Lower Cost Proton Therapy System $ 244,479.24  
ConjuGon, Inc Novel Therapeutic for the Prevention of Catheter Associated Urinary Tract Infections $ 126,059.50 $ 118,419.74
Core Products International, Inc Effects of a Novel Compound Ibuprofen Cream in the Management of Back and Knee Pain $ 31,750.00 $ 212,729.24
Cytometix, Inc Peptide Therapy for Asthma $ 22,625.00 $ 141,119.50
Cytometix, Inc. Lipid Therapeutics for ain $ 92,000.00 $ 152,479.25
Deltanoid Pharmaceuticals Inc DAB-8 to control serum phosphorus  in patients with chronic kidney disease (CKD) $ 192,718.00 $ 51,761.24
Deltanoid Pharmaceuticals Inc 2MD for treatment of postmenopausal osteoporosis $ 156,026.00 $ 32,395.00
Deltanoid Pharmaceuticals, Inc 2MD to slow the progression of chronic kidney disease and prevent end-stage renal disease $ 189,883.00 $ 54,596.24
ENDECE, LLC NDC-1308: anovel anticancer therapeutic for controlling tumor growth $ 244,479.24  
EraGen Biosciences Inc Development and commercialization of FDA approved HSV 1&2 molecular diagnostic kit $ 244,479.25  
Eso-Technologies Inc. New Approaches to a Minimally-Invasive Cardiac Monitoring System $ 152,919.50 $ 91,559.75
Exact Sciences Corporation Exact Sciences' Next Generation Colorectal Cancer (CRC) Screening Test $ 244,479.24  
Flex Biomedical, Inc. Flex Polymer: Novel Treatment for Osteoarthritis $ 210,510.00 $ 33,969.24
FluGen, Inc FP-An Antiviral Against Influenza   $ 147,914.50
FluGen, Inc Intradermal Microneedle Patch for Influenza Vaccine Delivery. $ 244,479.24  
FluGen, Inc. Cell based M2KO LAIV $ 118,156.09 $ 87,495.79
Genetic Testing Institute, Inc PF4 Rapid Test $ 85,899.00 $ 158,580.25
InvivoSciences, LLC Therapeutics to treat cardiac fibrosis $ 115,504.49 $ 128,974.76
ioGenetics LLC Directed Biocide anticryptosporidial therapeutics $ 244,479.25  
Isomark LLC Novel system for early detection of sepsis in the critically ill intensive care patient $ 5,734.45 $ 66,200.00
Kenergy, Inc. Unconditional MRI Compatible Implantable pacemaker and Defibrillator $ 244,479.24  
Mithridion, Inc Development of first-in-class M1 and M4 agonist drugs for Alzheimer's and schizophrenia. $ 244,479.24  
MORTARA INSTRUMENT, INC. ELI 230 Value Electrocardiograph for Early Detection of Atrial Fibrillation $ 244,479.25  
MORTARA INSTRUMENT, INC. Mortara ELI PC, Device for Low Cost Digital Acquisition of ECG Data in New Drug Development $ 200,069.50 $ 44,409.75
NanoMedex Pharmaceuticals Inc Manotechnology Drug Formulation $ 93,257.94 $ 151,221.31
NanoOncology Preclinical development of a nanoparticle drug to treat lung cancer   $ 244,479.25
Nerites Corporation Dural Membrane Sealant $ 244,479.25  
NeurEndo Pharma LLC Neuro-endocrine control as treatment for Type-2 diabetes and other metabolic disorders. $ 72,500.00 $ 171,979.25
NeuWave Medical, Inc Therapeutic Microwave Energy Delivery to Treat Cancer Tumors $ 244,479.25  
NorthStar Medical Radiostopes LLC Production and purification of Ac225/Bi213 alpha-emitting isotopes used in delivery of therapeutic molecules for the destruction of cancer cells $ 210,580.00 $ 33,899.25
Perscitus Biosciences LLC Compsitions and Method for Protecting Cells from Toxic Compounds $ 32,866.50 $ 211,612.75
Pharmasan Labs , Inc Immune Tolerance Test (ITT)-Cytokine Platform Project $ 172,146.03 $ 72,333.22
Pharming Healthcare Inc rhC1NH: Treatment of Hereditary Angioedema and other Clinical Applications $ 244,479.25  
Pharming Healthcare Inc Recombinant Human Fibringen for treatment of fibrinogen deficiencies $ 244,479.25  
PreventionGenetics LLC High Density Gene-Centric Deletion and Amplification Array CGH   $ 79,250.50
ProCertus BioPharm Inc Prevention of oral mucositis in patients receiving cancer treatments $ 62,090.50 $ 111,598.00
Promentis Pharmaceuticals, Inc Cystine-Glutamate Exchange Project $ 45,995.50 $ 198,483.74
Quintessence Biosciences Inc Naked Evade [tm] Rnase QBI-139 for cancer product development $ 244,479.24  
Ratio Inc Development of a novel drug delivery device: Ratio's microneedle pump-patch $ 12,652.00 $ 137,750.00
Scarab Genomics, LLC Treatment for Sepsis and Related Syndromes $ 187,377.91 $ 57,101.34
Smoke-Break Inc Smoke-Break Liquid Nicotine Despenser $ 13,898.50 $ 169,460.50
Spectrocon International LLC Therapeutic management of venous congestion with AutoFlow, a novel medical device $ 203,001.50 $ 41,477.75
StableBody Technologies, LLC Antibody Stabilization Technology for Therapeutic Drug Applications   $ 232,436.00
Stemina Biomarker Discovery Biomarkers of Cardiomyopathy $ 19,100.89 $ 20,134.23
Stemina Biomarker Discovery Biomarkers of Autism $ 785.29 $ 30,800.34
Stratatech Corporation Development and Clinical Evaluation of Novel Advanced Wound Care Therapies $ 244,479.25  
Waypoint Health Innovations, LLC COPE Development Project $ 41,620.84 $ 124,853.17
Wilson-Hurd Manufacturing Company INEEDMD 12-Lead ECG Glove Project $ 139,950.00 $ 104,529.25
ZyStor Therapeutics, Inc. XC-701 for the treatment of Pompe disease $ 244,479.25  

Rate the Small Business and Self-Employed Website

Page Last Reviewed or Updated: 15-Oct-2014